• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肌梗死后补充 n-3 多不饱和脂肪酸和维生素 E:GISSI-Prevenzione 试验结果。意大利心肌梗死存活研究组

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.

出版信息

Lancet. 1999 Aug 7;354(9177):447-55.

PMID:10465168
Abstract

BACKGROUND

There is conflicting evidence on the benefits of foods rich in vitamin E (alpha-tocopherol), n-3 polyunsaturated fatty acids (PUFA), and their pharmacological substitutes. We investigated the effects of these substances as supplements in patients who had myocardial infarction.

METHODS

From October, 1993, to September, 1995, 11,324 patients surviving recent (< or = 3 months) myocardial infarction were randomly assigned supplements of n-3 PUFA (1 g daily, n=2836), vitamin E (300 mg daily, n=2830), both (n=2830), or none (control, n=2828) for 3.5 years. The primary combined efficacy endpoint was death, non-fatal myocardial infarction, and stroke. Intention-to-treat analyses were done according to a factorial design (two-way) and by treatment group (four-way).

FINDINGS

Treatment with n-3 PUFA, but not vitamin E, significantly lowered the risk of the primary endpoint (relative-risk decrease 10% [95% CI 1-18] by two-way analysis, 15% [2-26] by four-way analysis). Benefit was attributable to a decrease in the risk of death (14% [3-24] two-way, 20% [6-33] four-way) and cardiovascular death (17% [3-29] two-way, 30% [13-44] four-way). The effect of the combined treatment was similar to that for n-3 PUFA for the primary endpoint (14% [1-26]) and for fatal events (20% [5-33]).

INTERPRETATION

Dietary supplementation with n-3 PUFA led to a clinically important and statistically significant benefit. Vitamin E had no benefit. Its effects on fatal cardiovascular events require further exploration.

摘要

背景

关于富含维生素E(α-生育酚)、n-3多不饱和脂肪酸(PUFA)及其药物替代品的益处,证据存在冲突。我们研究了这些物质作为补充剂对心肌梗死患者的影响。

方法

从1993年10月至1995年9月,11324例近期(≤3个月)心肌梗死存活患者被随机分配接受n-3多不饱和脂肪酸补充剂(每日1克,n = 2836)、维生素E(每日300毫克,n = 2830)、两者联合补充剂(n = 2830)或不补充(对照组,n = 2828),为期3.5年。主要联合疗效终点为死亡、非致命性心肌梗死和中风。意向性分析根据析因设计(双向)和治疗组(四向)进行。

结果

n-3多不饱和脂肪酸治疗可显著降低主要终点风险,但维生素E无此作用(双向分析相对风险降低10%[95%CI 1 - 18],四向分析为15%[2 - 26])。获益归因于死亡风险降低(双向14%[3 - 24],四向20%[6 - 33])和心血管死亡风险降低(双向17%[3 - 29],四向30%[13 - 44])。联合治疗对主要终点(14%[1 - 26])和致命事件(20%[5 - 33])的效果与n-3多不饱和脂肪酸相似。

解读

膳食补充n-3多不饱和脂肪酸带来了临床上重要且具有统计学意义的益处。维生素E无益处。其对致命心血管事件的影响需要进一步探索。

相似文献

1
Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.心肌梗死后补充 n-3 多不饱和脂肪酸和维生素 E:GISSI-Prevenzione 试验结果。意大利心肌梗死存活研究组
Lancet. 1999 Aug 7;354(9177):447-55.
2
Efficacy of n-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.心肌梗死后n-3多不饱和脂肪酸的疗效:GISSI-Prevenzione试验结果。意大利心肌梗死存活研究组
Lipids. 2001;36 Suppl:S119-26. doi: 10.1007/s11745-001-0694-8.
3
Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione.心肌梗死后n-3多不饱和脂肪酸对猝死的早期保护作用:意大利心肌梗死存活研究组(GISSI)-预防研究结果的时间进程分析
Circulation. 2002 Apr 23;105(16):1897-903. doi: 10.1161/01.cir.0000014682.14181.f2.
4
Antiarrhythmic mechanisms of n-3 PUFA and the results of the GISSI-Prevenzione trial.n-3多不饱和脂肪酸的抗心律失常机制及GISSI-Prevenzione试验结果
J Membr Biol. 2005 Jul;206(2):117-28. doi: 10.1007/s00232-005-0788-x.
5
Highly purified omega-3 polyunsaturated fatty acids are effective as adjunct therapy for secondary prevention of myocardial infarction.高纯度的ω-3多不饱和脂肪酸作为心肌梗死二级预防的辅助治疗有效。
Herz. 2006 Dec;31 Suppl 3:49-59.
6
The Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardio (GISSI)-Prevenzione Trial on fish oil and vitamin E supplementation in myocardial infarction survivors.意大利心肌梗死存活研究组(GISSI)-心肌梗死幸存者补充鱼油和维生素E的预防试验。
Curr Cardiol Rep. 2000 Sep;2(5):445-51. doi: 10.1007/s11886-000-0059-5.
7
Results of the low-dose (20 mg) pravastatin GISSI Prevenzione trial in 4271 patients with recent myocardial infarction: do stopped trials contribute to overall knowledge? GISSI Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico).低剂量(20毫克)普伐他汀在4271例近期心肌梗死患者中的GISSI预防试验结果:停止的试验对整体知识有贡献吗?GISSI预防研究组(意大利心肌梗死存活研究组)
Ital Heart J. 2000 Dec;1(12):810-20.
8
Cost-effectiveness analysis of n-3 polyunsaturated fatty acids (PUFA) after myocardial infarction: results from Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-Prevenzione Trial.心肌梗死后n-3多不饱和脂肪酸(PUFA)的成本效益分析:意大利心肌梗死存活研究组(GISSI)-预防试验的结果
Pharmacoeconomics. 2001;19(4):411-20. doi: 10.2165/00019053-200119040-00008.
9
Coffee consumption and risk of cardiovascular events after acute myocardial infarction: results from the GISSI (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico)-Prevenzione trial.急性心肌梗死后咖啡摄入量与心血管事件风险:GISSI(意大利心肌梗死存活研究组)-预防试验的结果
Circulation. 2007 Dec 18;116(25):2944-51. doi: 10.1161/CIRCULATIONAHA.107.712976. Epub 2007 Dec 3.
10
[The biochemical, pharmacological and epidemiological reference picture of the GISSI-Prevention. The Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].[GISSI预防研究的生化、药理学和流行病学参考情况。意大利心肌梗死链激酶研究组]
G Ital Cardiol. 1993 Sep;23(9):933-64.

引用本文的文献

1
Association Between Low Omega-6 Polyunsaturated Fatty Acid Levels and the Development of Delirium in the Coronary Intensive Care Unit.冠状动脉重症监护病房中低ω-6多不饱和脂肪酸水平与谵妄发生之间的关联
Nutrients. 2025 Jun 11;17(12):1979. doi: 10.3390/nu17121979.
2
The overlooked impact of background diet and adherence in nutrition trials.营养试验中背景饮食和依从性被忽视的影响。
Food Funct. 2025 Jun 26. doi: 10.1039/d5fo01134e.
3
Lysosomal Stress in Cardiovascular Diseases: Therapeutic Potential of Cardiovascular Drugs and Future Directions.
心血管疾病中的溶酶体应激:心血管药物的治疗潜力及未来方向
Biomedicines. 2025 Apr 27;13(5):1053. doi: 10.3390/biomedicines13051053.
4
Polyunsaturated Fatty Acids Improved Long Term Prognosis by Reducing Oxidative Stress, Inflammation, and Endothelial Dysfunction in Acute Coronary Syndromes.多不饱和脂肪酸通过降低急性冠脉综合征中的氧化应激、炎症和内皮功能障碍改善长期预后。
Mar Drugs. 2025 Apr 1;23(4):154. doi: 10.3390/md23040154.
5
The EPA oxylipin, 12-HEPE, directly regulates human platelet activity.美国环境保护局的氧化脂质12-羟基二十碳五烯酸(12-HEPE)直接调节人体血小板活性。
J Lipid Res. 2025 May;66(5):100807. doi: 10.1016/j.jlr.2025.100807. Epub 2025 Apr 16.
6
Lipids and Polyunsaturated Fatty Acids: Potential Applications and Strain Improvement.脂质与多不饱和脂肪酸:潜在应用及菌株改良
Mar Drugs. 2025 Mar 15;23(3):128. doi: 10.3390/md23030128.
7
Vitamin E (α-Tocopherol): Emerging Clinical Role and Adverse Risks of Supplementation in Adults.维生素E(α-生育酚):成人补充剂的新兴临床作用及不良风险
Cureus. 2025 Feb 7;17(2):e78679. doi: 10.7759/cureus.78679. eCollection 2025 Feb.
8
The overlooked impact of background diet and adherence in nutrition trials.营养试验中背景饮食和依从性被忽视的影响。
medRxiv. 2025 Feb 26:2025.02.26.25322933. doi: 10.1101/2025.02.26.25322933.
9
A Bayesian analysis of the VITAL trial: effects of ω-3 fatty acid supplementation on cardiovascular events.VITAL试验的贝叶斯分析:ω-3脂肪酸补充剂对心血管事件的影响。
Am J Clin Nutr. 2025 May;121(5):1046-1053. doi: 10.1016/j.ajcnut.2025.02.028. Epub 2025 Mar 1.
10
The Role of Omega-3 Polyunsaturated Fatty Acids in Patients with Metabolic Syndrome and Endothelial Dysfunction.ω-3多不饱和脂肪酸在代谢综合征和内皮功能障碍患者中的作用。
Medicina (Kaunas). 2024 Dec 30;61(1):43. doi: 10.3390/medicina61010043.